Abstract
The study objective was to compare the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A plus an upper limb therapy programme with the upper limb therapy programme alone. A multicentre open-label parallel-group randomised controlled trial and economic evaluation was carried out. Twelve stroke services in the north of England, UK. Participants: Three hundred and thirty-three adults with upper limb spasticity at the shoulder, elbow, wrist or hand and reduced upper limb function due to stroke more than 1 month previously.
Original language | English |
---|---|
Journal | Health Technology Assessment |
Volume | 14 |
Issue number | 26 |
Publication status | Published - 1 May 2010 |
Keywords
- botulinum toxin
- stroke
- randomized controlled trial
- upper limb
- spasticity
- economic analysis